These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12958096)

  • 1. NICE issues guidance on diabetes treatments.
    Iles A
    BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958096
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR
    Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thiazolidinediones in type 2 diabetes].
    Baum U
    Med Monatsschr Pharm; 2000 Jul; 23(7):210-3. PubMed ID: 10941251
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes. Type-righting lessons.
    Bryan J
    Health Serv J; 2000 Nov; 110(5733):suppl 11-2. PubMed ID: 11138528
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosiglitazone and type 2 diabetes mellitus.
    Bragg T
    Lancet; 2001 May; 357(9266):1451. PubMed ID: 11360960
    [No Abstract]   [Full Text] [Related]  

  • 6. The failings of NICE. NICE's guidance suggests using rosiglitazone in type 2 diabetes later than is ideal.
    Robinson S; Valabhji J; Schachter M
    BMJ; 2001 Feb; 322(7284):491. PubMed ID: 11222431
    [No Abstract]   [Full Text] [Related]  

  • 7. Pioglitazone: the future.
    Brunetti P
    Int J Clin Pract Suppl; 2001 Sep; (121):36. PubMed ID: 11594244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thiazolidinediones].
    Scheen AJ; Paquot N; Letiexhe MR; Lefèbvre PJ
    Journ Annu Diabetol Hotel Dieu; 1999; ():213-29. PubMed ID: 10732419
    [No Abstract]   [Full Text] [Related]  

  • 9. Warner Lambert/Sankyo diabetes drug nears market.
    Nat Biotechnol; 1997 Feb; 15(2):113. PubMed ID: 9035120
    [No Abstract]   [Full Text] [Related]  

  • 10. New treatment for adult-onset diabetes.
    Zurlinden J
    Nurs Spectr (Wash D C); 1997 Aug; 7(16):8. PubMed ID: 9439332
    [No Abstract]   [Full Text] [Related]  

  • 11. Honing type 2 diabetes treatment.
    Blackburn G
    Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
    Algenstaedt P; Hamann A
    Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
    [No Abstract]   [Full Text] [Related]  

  • 13. Rosiglitazone monotherapy and type 2 diabetes.
    Lawrence IG
    Diabet Med; 2001 Nov; 18 Suppl 4():6-8. PubMed ID: 11989215
    [No Abstract]   [Full Text] [Related]  

  • 14. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
    Böhm S
    MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular risk reduction with pioglitazone.
    Cardiovasc J S Afr; 2002; 13(4):218. PubMed ID: 12402932
    [No Abstract]   [Full Text] [Related]  

  • 16. Troglitazone.
    Santiago JV
    Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
    [No Abstract]   [Full Text] [Related]  

  • 17. Pioglitazone (Actos).
    Med Lett Drugs Ther; 1999 Nov; 41(1066):112. PubMed ID: 10987011
    [No Abstract]   [Full Text] [Related]  

  • 18. Conference urges further consultation on NICE diabetes guidance.
    Hawkes N
    BMJ; 2015 Jun; 350():h3203. PubMed ID: 26068012
    [No Abstract]   [Full Text] [Related]  

  • 19. [New prospects for the type 2 diabetic patient. Delaying disease progression].
    MMW Fortschr Med; 2000 Nov; 142(46):56-7. PubMed ID: 11138590
    [No Abstract]   [Full Text] [Related]  

  • 20. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.